drugset / Trial / NCT00570011
Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients
Phase 3
Completed
112 enrolled
Eli Lilly and Company
University of Milan · collabUniversity of Naples · collabUniversity of Padova · collabUniversity of Pisa · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
An international study in which patients with GHD were randomized to receive somatropin at a dose of either 3 microg/kg/day or 6 microg/kg/day for the first three months. The dose was then doubled (6 microg/kg/day, LD or 12 microg/kg/day, CD) for the next three-months.
Timeline
- Start
- 1997-06
- Primary completion
- —
- Completion
- 1998-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatropin | Protein / enzyme biologic | 6 ug/kg | — |
| Subject | Somatropin | Protein / enzyme biologic | 12 ug/kg | — |